期刊
CHEMMEDCHEM
卷 6, 期 5, 页码 826-833出版社
WILEY-BLACKWELL
DOI: 10.1002/cmdc.201000555
关键词
antiviral agents; DABOs; HIV-1; medicinal chemistry; NNRTIs
资金
- Graduate Independent Innovation Foundation of Shandong University (GIIFSDU) [21310070613090]
- Natural Science Foundation of China (NSFC) [30928032, 30873133, 30772629, 30371686]
- NSFC for International Cooperation [30910103908]
- Research Fund for the Doctoral Program of Higher Education of China [20070422083]
A series of new 5-alkyl-2-phenylaminocarbonylmethylthiopyrimidin-4(3H)-ones bearing variously substituted arylmethyl moieties at the C6 position of the pyrimidine ring were synthesized and evaluated for anti-HIV activity in MT-4 cells. Most of these new congeners exhibited moderate to good activities against the wild-type virus, with EC(50) values in the range of 1.40-0.19 mu m. Among them, 2-[(4-cyanophenylamino)carbonylmethylthio]- 6-(2-chloro-6-fluorobenzyl)-5-ethylpyrimidin-4(3H)-one 4b6 is one of the compounds endowed with the highest broad-spectrum HIV-1 inhibitory activity, with EC(50) values of .19 +/- 0.005 mu m against the wild-type virus, 1.05 +/- 0.24 mu m (twofold resistance) against the E138K strain, and 2.38 +/- 0.13 mu m (4.5-fold resistance) against the Y181C strain. Furthermore, reverse transcriptase (RT) inhibition assays against wildtype HIV-1 RT were performed with selected derivatives, confirming that the main target of these compounds is HIV-1 RT and that these new S-DABO analogues act as non-nucleoside RT inhibitors (NNRTIs). Structure-activity relationship and molecular modeling analyses of these new congeners are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据